BRIDGEWATER, N.J. and BENGALURU, India, April 10, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the ...

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced that the U.S. Food and Drug Administration (U.S. FDA) has approved Jobevnetm (bevacizumab-nwgd), ...

IQVIA Holdings Inc. closed 42.44% below its 52-week high of $252.88, which the company reached on August 29th.

Barclays downgraded Iqvia (IQV) to Equal Weight from Overweight with a price target of $170, down from $235. The firm moved to the sidelines on ...

Shares of IQVIA Holdings Inc. IQV slipped 8.79% to $143.22 Thursday, on what proved to be an all-around poor trading session ...

Truist analyst Jailendra Singh lowered the firm’s price target on Iqvia (IQV) to $216 from $263 and keeps a Buy rating on the shares as part of ...

IQVIA Holdings experienced a price decline of 13% last week, coinciding with their decision to amend their Fifth Amended and Restated Credit Agreement by introducing new Term B Dollar Loans ...

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional ...

Emergen Research Logo The Healthcare Payer Services market is expected to grow from an estimated USD 76.4 billion in 2024 to USD 177.2 bill ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...